Clinical Trial

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for TBI

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of traumatic brain injury
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-08-20; most recent amendment 2025-04-15.
Status change: Recruiting → Not Yet Recruiting 2022-07-20
Trial Details
NCT Number NCT05018832
Lead Sponsor The Foundation for Orthopaedics and Regenerative Medicine
Conditions Traumatic Brain Injury
Enrollment 20 participants
Start Date 2025-12
Primary Completion 2028-11 (estimated)
Study Completion 2028-11 (estimated)
Updated on ClinicalTrials.gov 2025-04-17